uridine triphosphate has been researched along with Chronic Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donohue, JF; Johnson, FL; Shaffer, CL | 1 |
| Earley, S; Walker, BR | 1 |
| Burnstock, G; Giniyatova, LR; Jourjikiya, RK; Khaziakhmetov, DF; Khaziakhmetova, VN; Ziganshin, AU; Ziganshin, BA; Ziganshina, LE | 1 |
| Broughton, BR; Jernigan, NL; Resta, TC; Walker, BR | 1 |
| Tamaoki, J | 1 |
| Bennett, WD; Foy, C; Johnson, FL; Johnson, J; Regnis, JA; Sannuti, A; Shaffer, CL; Zeman, KL | 1 |
1 review(s) available for uridine triphosphate and Chronic Disease
| Article | Year |
|---|---|
[Mechanism and management of airway hypersecretion in obstructive lung disease].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Autonomic Nervous System; Bronchitis; Chronic Disease; Cytokines; Glycoproteins; Humans; Ion Transport; Mucins; Mucociliary Clearance; Respiratory Mucosa; Steroids; Uridine Triphosphate | 1999 |
2 trial(s) available for uridine triphosphate and Chronic Disease
| Article | Year |
|---|---|
Improved sputum expectoration following a single dose of INS316 in patients with chronic bronchitis.
Topics: Adult; Bronchitis; Chronic Disease; Cross-Over Studies; Double-Blind Method; Expectorants; Female; Humans; Macrophages; Male; Middle Aged; Safety; Sputum; Uridine Triphosphate | 2002 |
Effect of aerosolized uridine 5'-triphosphate on mucociliary clearance in mild chronic bronchitis.
Topics: Administration, Inhalation; Adult; Bronchitis; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Mucociliary Clearance; Severity of Illness Index; Uridine Triphosphate | 2001 |
3 other study(ies) available for uridine triphosphate and Chronic Disease
| Article | Year |
|---|---|
Increased nitric oxide production following chronic hypoxia contributes to attenuated systemic vasoconstriction.
Topics: Animals; Blotting, Western; Calcium; Chronic Disease; Endothelium, Vascular; Hypoxia; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Purinergic Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic; Uridine Triphosphate; Vasoconstriction | 2003 |
Varicose disease affects the P2 receptor-mediated responses of human greater saphenous vein.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Animals; Arteriosclerosis Obliterans; Carbachol; Chronic Disease; Dose-Response Relationship, Drug; Female; Histamine; Humans; Leg; Male; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Saphenous Vein; Uridine Triphosphate; Varicose Veins | 2004 |
Impaired NO-dependent inhibition of store- and receptor-operated calcium entry in pulmonary vascular smooth muscle after chronic hypoxia.
Topics: Animals; Bronchodilator Agents; Calcium; Calcium Channels; Calcium-Transporting ATPases; Chronic Disease; Endothelium, Vascular; Enzyme Inhibitors; Hypertension, Pulmonary; Hypoxia; Indoles; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Spermine; Uridine Triphosphate | 2006 |